查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
体外肺模型市场：成长、未来前景、竞争分析，2024-2032 年
市场调查报告书
商品编码
1517845

体外肺模型市场：成长、未来前景、竞争分析，2024-2032 年

In Vitro Lung Model Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
出版日期: | 出版商: Acute Market Reports | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

体外肺模型市场是医学研究和生物技术广泛领域中的一个特殊领域。该市场专注于模拟人类肺结构和功能的体外模型的开发、生产和利用。这些模型对于呼吸研究、药物发现和毒性测试等各种应用至关重要。预计 2024 年至 2032 年，体外肺模型市场将以 17.2% 的复合年增长率成长。体外肺模型是模仿人类肺部生物学特性的实验室模型。它将使用多种技术进行开发，包括细胞培养、器官晶片技术和 3D 生物列印。这些模型旨在重现肺部的细胞环境、结构特征和生理反应，为传统动物实验提供更准确、更合乎伦理的替代方案。

促进因素：对先进呼吸系统疾病研究的需求不断增加

体外肺模型市场的主要驱动力是对先进呼吸系统疾病研究日益增长的需求。这项需求是由慢性阻塞性肺病 (COPD)、气喘和肺癌等呼吸道疾病在全球日益流行所推动的。根据世界卫生组织 (WHO) 的数据，慢性阻塞性肺病 (COPD) 是世界第三大死因，而气喘则影响着全球数百万人。呼吸系统疾病负担的增加需要更有效的研究工具来瞭解疾病机制、开发新的治疗方法并改善患者的治疗结果。体外肺模型提供了一种有前途的解决方案，它为动物实验提供了更准确和道德的替代方案，并允许在细胞和分子层面上对肺部疾病进行详细研究。随着世界各地的科学家利用体外肺模型来研究病毒对肺组织的影响并测试潜在的治疗方法，COVID-19 大流行进一步强化了肺部研究的重要性。这凸显了这些模型在呼吸系统疾病研究和药物开发中的重要作用，推动了市场的显着成长。

机会：肺模型的技术进步

由于肺部模型开发的技术进步，体外肺模型市场提供了巨大的机会。 3D 生物列印和器官晶片技术等创新正在彻底改变该领域，从而能够创建更复杂且与生理相关的肺部模型。这些进步不仅提高了药物疗效和毒性测试的准确性，也为个人化医疗开闢了新途径。例如，使用来自特定患者的细胞开发肺部模型的能力可能会实现更个性化的药物反应测试和客製化治疗的发展。这些技术进步符合个人化医疗和精准医疗的成长趋势，为市场成长创造了利润丰厚的机会。随着这些技术的不断成熟和变得更加容易获得，体外肺模型的应用和功能预计将显着扩展。

抑制因素：成本高、技术复杂

儘管体外肺模型具有潜力，但该市场面临高成本和技术复杂性的主要限制因素。开发和维护复杂的肺部模型，特别是那些使用晶片器官等尖端技术的模型，需要大量的财务投资。这些技术相关的高成本可能会对学术机构和小型研究机构构成障碍，限制先进肺模型的传播。此外，创建和使用这些模型所涉及的技术复杂性需要专门的专业知识和资源。这不仅增加了成本，而且限制了能够有效利用这些模型进行研究目的的熟练专业人员的可用性。因此，先进体外肺部模型的高成本和技术复杂性仍然是市场上的主要课题，并可能阻碍更广泛的采用和创新。

课题：再现人肺的复杂性

体外肺模型市场面临的最大课题之一是重建人类肺部的复杂结构。肺部是一个高度复杂的器官，具有独特的结构和多样化的细胞类型，因此很难在实验室中准确模拟。儘管最近的技术进步在这一领域取得了重大进展，但目前体外模型的能力与真实人类肺部的复杂性之间仍然存在差距。这个问题极为重要，因为肺模型在研究和药物开发中的有效性很大程度上取决于它们再现人类肺生理和病理的准确程度。克服这项课题需要持续的研究和创新，以开发更复杂的模型，能够忠实地模拟人类肺部的复杂结构、细胞多样性和动态生理反应。解决这个问题对于体外肺模型在呼吸研究中的持续进步和实用至关重要。

市场区隔：依类型

在体外肺模型市场中，依类型细分包括2D模型和3D模型，每种模型都有不同的成长模式和收入贡献。 3D模型目前占市场销售量最高。这项优势归功于 3D 模型能够忠实再现人类肺部结构和功能的先进能力，使其在药物发现和疾病建模的复杂研究中具有极高的价值。与传统的 2D 文化相比，它在先进的研究环境中被广泛采用，因为它提供了更生理相关的环境。 3D 模型在复杂性肺部疾病研究和呼吸系统药物疗效测试中的使用不断增加，进一步增强了其收入优势。然而，预计复合年增长率 (CAGR) 最高的是 2D 建模领域。虽然 3D 模型提供了高级功能，但 2D 模型由于其简单、成本低且易于使用，仍然被广泛使用。对 2D 模型的需求预计将成长，特别是基础研究和日常检查，这可能不需要 3D 模型的复杂性和成本。

市场区隔：依应用划分

依应用划分的市场细分包括药物发现/毒性研究、生理研究、3D模型开发等。由于这些模型在製药业中发挥的重要作用，药物发现和毒理学研究领域产生了最高的收入。这些模型广泛用于潜在候选药物的筛选和毒性评估，显着减少与药物开发相关的时间和成本。药物研发投资的增加以及对新型呼吸系统药物的需求不断增加，特别是在 COVID-19 大流行之后，正在推动该领域的成长。就复合年增长率最高而言，生理学研究领域预计将成长最快。这种增长是由对从根本上瞭解复杂肺部疾病的日益增长的需求所推动的，包括对慢性阻塞性肺病、气喘和肺癌等疾病的病理生理学的研究。随着科学界对这些疾病的瞭解不断增加，对模拟人类肺部生理学的更复杂、更准确的模型的需求预计将显着增加生理研究中对体外肺模型的需求。

区域洞察

体外肺模型市场的地理细分凸显了不同地区不同的成长和收入模式。 2023 年，北美成为该市场最赚钱的地区。这一领先地位归功于该地区先进的医疗保健研究基础设施、对研发的大量投资以及从事肺部相关研究的主要製药和生物技术公司的存在。北美呼吸系统疾病的高盛行率以及我们对开发创新治疗解决方案的专注也促成了北美的压倒性销售。预计 2024 年至 2032 年，亚太地区的复合年增长率 (CAGR) 最高。这项成长预测的推动因素包括中国和印度等国家对医疗保健研究投资的增加、呼吸系统疾病盛行率的上升以及对先进研究技术的认识的提高。此外，扩大医疗基础设施和增加政府对这些地区生物技术研究的支持可能会促进体外肺模型市场的成长。

竞争趋势

就竞争趋势而言，市场的特征是既有成熟企业，也有新兴企业，每个企业都采取独特的策略来巩固其市场地位。到 2023 年，Epithelix、MATTEK、Lonza、Emulate、AlveoliX AG、Nortis、CN Bio Innovations、MIMETAS、InSphero 和 ATTC Global 等公司将成为顶级参与者，利用其强大的研究能力和强大的产品组合扩大其主导地位市场。这些公司专注于策略联盟、併购和收购，以扩大其技术能力和市场覆盖范围。在2024年至2032年的预测期内，这些领先公司预计将继续强调技术创新，特别是在3D生物列印和器官晶片技术等领域。投资这些先进技术预计将成为保持竞争力的重要策略。此外，这些公司将扩大在新兴市场的影响力，同时适应不断变化的研究需求和监管环境。专门从事创新肺部模型技术的新进入者的进入预计将加剧市场竞争，并促进体外肺部模型领域的持续发展。

本报告回答的主要问题

影响体外肺模型市场成长的关键微观和宏观环境因素有哪些？

现在和预测期内产品细分和地区的主要投资领域是什么？

2032 年之前的预估与市场预测

预测期间哪个细分市场的复合年增长率最快？

哪个细分市场拥有较大的市场占有率，为什么？

低收入和中等收入国家是否正在投资体外肺模型市场？

体外肺模型市场最大的区域市场是哪一个？

亚太地区、拉丁美洲和中东/非洲等新兴市场的市场趋势和动态是什么？

推动体外肺模型市场成长的主要趋势是什么？

主要竞争对手是什么？

目录

第一章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 主要优惠
  • 市场区隔
  • 调查方法
    • 第一阶段-二次调查
    • 第二阶段 - 初步调查
    • 第三阶段-专家评审
    • 先决条件
    • 采用的方法

第 2 章执行摘要

第三章体外肺模型市场：竞争分析

  • 主要供应商的市场定位
  • 供应商采取的策略
  • 主要产业战略
  • 层级分析：2023 年与 2032 年

第四章体外肺模型市场：宏观分析与市场动态

  • 简介
  • 2022-2032年全球体外肺模型市场价值
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 主要课题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析
  • 波特的五力模型
    • 供应商实力
    • 买家力量
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的对抗关係
  • PESTEL 分析
    • 政治局势
    • 经济情势
    • 技术状况
    • 法律状况
    • 社会状况

第五章体外肺模型市场：依类型2022-2032

  • 市场概览
  • 成长/利润分析：2023 年与 2032 年
  • 市场区隔
    • 二维模型
    • 3D模型

第六章体外肺模型市场：依应用划分2022-2032

  • 市场概览
  • 成长/利润分析：2023 年与 2032 年
  • 市场区隔
    • 药物发现/毒性研究
    • 生理研究
    • 3D模型开发
    • 其他

第七章体外肺模型市场：依最终用途 2022-2032

  • 市场概览
  • 成长/利润分析：2023 年与 2032 年
  • 市场区隔
    • 学术研究所
    • 製药和生技公司
    • 其他

第八章2022-2032年北美体外肺模型市场

  • 市场概览
  • 体外肺模型市场：依类型划分2022-2032年
  • 体外肺模型市场：依应用划分2022-2032年
  • 2022-2032 年依最终用途划分的体外肺模型市场
  • 体外肺模型市场：依地区划分2022-2032年
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第 9 章英国/欧盟体外肺模型市场 2022-2032

  • 市场概览
  • 体外肺模型市场：依类型划分2022-2032年
  • 体外肺模型市场：依应用划分2022-2032年
  • 2022-2032 年依最终用途划分的体外肺模型市场
  • 体外肺模型市场：依地区划分2022-2032年
    • 英国/欧盟
      • 英国
      • 德国
      • 西班牙
      • 义大利
      • 法国
      • 其他欧洲地区

第十章亚太体外肺模型市场2022-2032

  • 市场概览
  • 体外肺模型市场：依类型划分2022-2032年
  • 体外肺模型市场：依应用划分2022-2032年
  • 2022-2032 年依最终用途划分的体外肺模型市场
  • 体外肺模型市场：依地区划分2022-2032年
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区

第11章2022-2032年拉丁美洲体外肺模型市场

  • 市场概览
  • 体外肺模型市场：依类型划分2022-2032年
  • 体外肺模型市场：依应用划分2022-2032年
  • 2022-2032 年依最终用途划分的体外肺模型市场
  • 体外肺模型市场：依地区划分2022-2032年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第十二章中东与非洲体外肺模型市场2022-2032

  • 市场概览
  • 体外肺模型市场：依类型划分2022-2032年
  • 体外肺模型市场：依应用划分2022-2032年
  • 2022-2032 年依最终用途划分的体外肺模型市场
  • 体外肺模型市场：依地区划分2022-2032年
    • 中东/非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东/非洲地区

第十三章公司简介

  • Epithelix
  • MATTEK
  • Lonza
  • Emulate
  • AlveoliX AG
  • Nortis
  • CN Bio Innovations Ltd.
  • MIMETAS
  • InSphero
  • ATTC Global
  • 其他主要公司
Product Code: 527-07-24

The in vitro lung model market is a specialized segment within the broader field of medical research and biotechnology. This market focuses on the development, production, and utilization of in vitro (outside the living organism) models that simulate the structure and function of human lungs. These models are crucial for various applications in respiratory research, drug discovery, and toxicology testing. The in vitro lung model market is estimated to grow at a CAGR of 17.2% from 2024 to 2032. In vitro lung models are laboratory models that mimic the biological characteristics of human lungs. They are developed using various techniques, including cell cultures, organ-on-a-chip technology, and 3D bioprinting. These models aim to replicate the lung's cellular environment, structural features, and physiological responses, providing a more accurate and ethical alternative to traditional animal testing.

Driver: Growing Need for Advanced Respiratory Disease Research

The in vitro lung model market is primarily driven by the growing need for advanced respiratory disease research. This demand is fueled by the increasing prevalence of respiratory diseases globally, including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. According to the World Health Organization, COPD alone is the third leading cause of death worldwide, and asthma affects millions of people globally. This rising burden of respiratory diseases necessitates more effective research tools for understanding disease mechanisms, developing new treatments, and improving patient outcomes. In vitro lung models offer a promising solution by providing a more accurate and ethical alternative to animal testing, enabling detailed study of lung diseases at the cellular and molecular level. The COVID-19 pandemic further highlighted the importance of lung research, as scientists worldwide turned to in vitro lung models to study the virus's effects on lung tissue and test potential treatments. This has underscored the essential role of these models in respiratory disease research and drug development, driving significant growth in the market.

Opportunity: Technological Advancements in Lung Models

The in vitro lung model market presents significant opportunities with technological advancements in lung model development. Innovations such as 3D bioprinting and organ-on-a-chip technology are revolutionizing the field, enabling the creation of more complex and physiologically relevant lung models. These advancements are not only enhancing the accuracy of drug efficacy and toxicity testing but also opening new avenues in personalized medicine. For instance, lung models can now be developed using cells from specific patients, allowing for more personalized drug response testing and the potential development of customized treatments. This technological evolution aligns with the growing trend towards personalized healthcare and precision medicine, making it a lucrative opportunity for market growth. As these technologies continue to mature and become more accessible, they are expected to significantly expand the applications and capabilities of in vitro lung models.

Restraint: High Costs and Technical Complexities

Despite the potential of in vitro lung models, the market faces significant restraints in terms of high costs and technical complexities. Developing and maintaining sophisticated lung models, especially those using cutting-edge technologies like organ-on-a-chip, requires substantial financial investment. The high costs associated with these technologies can be a barrier for academic and smaller research institutions, limiting the widespread adoption of advanced lung models. Additionally, the technical complexities involved in creating and using these models require specialized expertise and resources. This not only adds to the cost but also limits the availability of skilled professionals who can effectively utilize these models for research purposes. As such, the high cost and technical complexity of advanced in vitro lung models remain major challenges in the market, potentially hindering broader adoption and innovation.

Challenge: Replicating the Complexity of Human Lungs

One of the biggest challenges in the in vitro lung model market is replicating the intricate complexity of human lungs. The lung is a highly complex organ with a unique structure and diverse cell types, making it difficult to accurately mimic in a laboratory setting. While recent technological advancements have made significant strides in this area, there is still a gap between the current capabilities of in vitro models and the complexity of real human lungs. This challenge is critical because the efficacy of lung models in research and drug development heavily depends on how accurately they replicate human lung physiology and pathology. Overcoming this challenge requires ongoing research and innovation to develop more sophisticated models that can closely mimic the intricate architecture, cellular diversity, and dynamic physiological responses of human lungs. Addressing this issue is essential for the continued advancement and utility of in vitro lung models in respiratory research.

Market segmentation by type

In the in vitro lung model market, segmentation by type includes 2D and 3D Models, each with distinct growth patterns and revenue contributions. The 3D Model segment currently holds the highest revenue within this market. This prominence is due to the advanced capabilities of 3D models in closely replicating the structural and functional aspects of human lungs, making them highly valuable for complex studies in drug discovery and disease modeling. Their ability to provide a more physiologically relevant environment compared to traditional 2D cultures has led to their widespread adoption in advanced research settings. The revenue dominance of 3D models is further reinforced by their increasing use in studying intricate lung diseases and testing the efficacy of respiratory drugs. However, the segment expected to exhibit the highest Compound Annual Growth Rate (CAGR) is the 2D Model segment. While 3D models offer advanced features, 2D models are still widely used due to their simplicity, lower cost, and ease of use. The demand for 2D models is expected to grow, particularly in basic research and routine testing, where the complexity and cost of 3D models may not be necessary.

Market Segmentation by Application

Regarding market segmentation by application, the in vitro lung model market includes Drug Discovery & Toxicology Studies, Physiological Research, 3D Model Development, among others. The Drug Discovery & Toxicology Studies segment has generated the highest revenue, attributed to the critical role these models play in the pharmaceutical industry. They are extensively used for screening potential drug candidates and assessing their toxicity, significantly reducing the time and cost associated with drug development. The increasing investment in pharmaceutical R&D, along with the rising demand for new respiratory drugs, especially post the COVID-19 pandemic, has fueled the growth of this segment. In terms of the highest CAGR, the Physiological Research segment is projected to grow rapidly. This growth is driven by the escalating need to understand complex lung diseases at a fundamental level, including studying the pathophysiology of conditions like COPD, asthma, and lung cancers. As the scientific community's understanding of these diseases deepens, the demand for in vitro lung models in physiological research is expected to increase significantly, driven by the need for more sophisticated and accurate models to mimic human lung physiology.

Regional Insights

The in vitro lung model market's geographic segmentation highlights varied growth and revenue patterns across different regions. In 2023, North America emerged as the region with the highest revenue in this market. This leadership can be attributed to the region's advanced healthcare research infrastructure, significant investments in R&D, and the presence of key pharmaceutical and biotech companies engaged in lung-related research. The high prevalence of respiratory diseases and the strong focus on developing innovative treatment solutions in North America further contributed to its dominant revenue position. Looking towards 2024 to 2032, the Asia-Pacific region is expected to experience the highest Compound Annual Growth Rate (CAGR). This growth projection is driven by increasing investments in healthcare research, rising incidence of respiratory diseases, and growing awareness of advanced research methodologies in countries like China and India. Additionally, the expanding healthcare infrastructure and increasing government support for biotechnology research in these regions are likely to fuel the growth of the in vitro lung model market.

Competitive Trends

In terms of competitive trends, the market is characterized by a mix of established players and emerging entrants, each employing distinct strategies to strengthen their market positions. In 2023, companies such as Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd., MIMETAS, InSphero, ATTC Global were among the top players, leveraging their extensive research capabilities and robust product portfolios to dominate the market. These companies focused on strategic collaborations, mergers, and acquisitions to broaden their technological capabilities and enhance their market reach. For the forecast period of 2024 to 2032, these key players are expected to continue emphasizing innovation, particularly in areas like 3D bioprinting and organ-on-a-chip technologies. Investment in these advanced technologies is anticipated to be a crucial strategy for maintaining a competitive edge. Furthermore, these companies are likely to expand their presence in emerging markets, adapting to the evolving research needs and regulatory landscapes. The entry of new players specializing in innovative lung model technologies is expected to intensify competition in the market, thereby driving continuous advancements in the field of in vitro lung models.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of In Vitro Lung Model market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the In Vitro Lung Model market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

Type

2D Model

3D Model

Application

    • Drug Discovery & Toxicology Studies
    • Physiological Research

3D Model Development

    • Others

End-Use

    • Academic Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Others

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of In Vitro Lung Model market?

What are the key investment pockets concerning product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the In Vitro Lung Model market?

Which is the largest regional market for In Vitro Lung Model market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving In Vitro Lung Model market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the In Vitro Lung Model market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global In Vitro Lung Model Market
  • 2.2. Global In Vitro Lung Model Market, By Type, 2023 (US$ Million)
  • 2.3. Global In Vitro Lung Model Market, By Application, 2023 (US$ Million)
  • 2.4. Global In Vitro Lung Model Market, By End-Use, 2023 (US$ Million)
  • 2.5. Global In Vitro Lung Model Market, By Geography, 2023 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2023

3. In Vitro Lung Model Market: Competitive Analysis

  • 3.1. Market Positioning of Key In Vitro Lung Model Market Vendors
  • 3.2. Strategies Adopted by In Vitro Lung Model Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. In Vitro Lung Model Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global In Vitro Lung Model Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. 2D Model
    • 5.3.2. 3D Model

6. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Drug Discovery & Toxicology Studies
    • 6.3.2. Physiological Research
    • 6.3.3. 3D Model Development
    • 6.3.4. Others

7. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Market Segmentation
    • 7.3.1. Academic Research Institutes
    • 7.3.2. Pharmaceutical & Biotechnology Companies
    • 7.3.3. Others

8. North America In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 8.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 8.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 8.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

9. UK and European Union In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 9.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 9.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 9.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.4.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.4.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.5.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.5.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.6.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.6.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

10. Asia Pacific In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 10.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 10.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 10.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.4.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.4.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.5.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.5.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.6.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.6.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

11. Latin America In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 11.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 11.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 11.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

12. Middle East and Africa In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 12.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 12.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 12.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

13. Company Profile

  • 13.1. Epithelix
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. MATTEK
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Lonza
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Emulate
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. AlveoliX AG
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Nortis
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. CN Bio Innovations Ltd.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. MIMETAS
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. InSphero
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. ATTC Global
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Other Notable Players
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 2 Global In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 3 Global In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 4 North America In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 5 North America In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 6 North America In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 7 U.S. In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 8 U.S. In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 9 U.S. In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 10 Canada In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 11 Canada In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 12 Canada In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 13 Rest of North America In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 14 Rest of North America In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 15 Rest of North America In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 16 UK and European Union In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 17 UK and European Union In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 18 UK and European Union In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 19 UK In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 20 UK In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 21 UK In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 22 Germany In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 23 Germany In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 24 Germany In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 25 Spain In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 26 Spain In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 27 Spain In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 28 Italy In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 29 Italy In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 30 Italy In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 31 France In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 32 France In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 33 France In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 34 Rest of Europe In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 35 Rest of Europe In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 36 Rest of Europe In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 37 Asia In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 38 Asia In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 39 Asia In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 40 China In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 41 China In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 42 China In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 43 Japan In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 44 Japan In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 45 Japan In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 46 India In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 47 India In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 48 India In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 49 Australia In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 50 Australia In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 51 Australia In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 52 South Korea In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 53 South Korea In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 54 South Korea In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 55 Latin America In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 56 Latin America In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 57 Latin America In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 58 Brazil In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 59 Brazil In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 60 Brazil In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 61 Mexico In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 62 Mexico In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 63 Mexico In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 64 Rest of Latin America In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 65 Rest of Latin America In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 66 Rest of Latin America In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 67 Middle East and Africa In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 68 Middle East and Africa In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 69 Middle East and Africa In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 70 GCC In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 71 GCC In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 72 GCC In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 73 Africa In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 74 Africa In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 75 Africa In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 76 Rest of Middle East and Africa In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 77 Rest of Middle East and Africa In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 78 Rest of Middle East and Africa In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global In Vitro Lung Model Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global In Vitro Lung Model Market: Quality Assurance
  • FIG. 5 Global In Vitro Lung Model Market, By Type, 2023
  • FIG. 6 Global In Vitro Lung Model Market, By Application, 2023
  • FIG. 7 Global In Vitro Lung Model Market, By End-Use, 2023
  • FIG. 8 Global In Vitro Lung Model Market, By Geography, 2023
  • FIG. 9 Market Geographical Opportunity Matrix - Global In Vitro Lung Model Market, 2023

FIG. 10Market Positioning of Key In Vitro Lung Model Market Players, 2023

FIG. 11Global In Vitro Lung Model Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 12 Global In Vitro Lung Model Market, By Type, 2023 Vs 2032, %
  • FIG. 13 Global In Vitro Lung Model Market, By Application, 2023 Vs 2032, %
  • FIG. 14 Global In Vitro Lung Model Market, By End-Use, 2023 Vs 2032, %
  • FIG. 15 U.S. In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 16 Canada In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 17 Rest of North America In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 18 UK In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 19 Germany In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 20 Spain In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 21 Italy In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 22 France In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 23 Rest of Europe In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 24 China In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 25 Japan In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 26 India In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 27 Australia In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 28 South Korea In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 29 Rest of Asia In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 30 Brazil In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 31 Mexico In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 32 Rest of Latin America In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 33 GCC In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 34 Africa In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 35 Rest of Middle East and Africa In Vitro Lung Model Market (US$ Million), 2022 - 2032